Excluded trial | No. of trials | No. of patients | Plate group | Nail group | RR (95 % CI) | P value for RR | I 2, % | P value for heterogeneity |
---|---|---|---|---|---|---|---|---|
Zhu 2011 | 564 | 99 of 322 | 68 of 242 | 1.06 (0.80, 1.41) | 0.68 | 5 | 0.39 | |
Smejkal 2011 | 560 | 96 of 320 | 60 of 240 | 1.05 (0.69, 1.60) | 0.80 | 41 | 0.12 | |
Gradl 2009 | 463 | 85 of 272 | 52 of 191 | 1.03 (0.67, 1.58) | 0.91 | 39 | 0.13 | |
Matziolis 2010 | 593 | 103 of 337 | 65 of 256 | 1.08 (0.73,1.60) | 0.70 | 41 | 0.12 | |
Trepat 2011 | 586 | 102 of 334 | 59 of 252 | 1.22 (0.90, 1.65) | 0.20 | 5 | 0.39 | |
Lekic 2012 | 592 | 103 of 336 | 64 of 256 | 1.12 (0.76, 1.64) | 0.56 | 37 | 0.15 | |
Konrad 2012 | 404 | 59 of 195 | 57 of 209 | 0.99 (0.66, 1.47) | 0.95 | 30 | 0.20 | |
Von 2014 | 543 | 102 of 320 | 58 of 223 | 1.13 (0.77, 1.65) | 0.53 | 36 | 0.15 |